Tirzepatide is a dual-action GLP-1 and GIP receptor agonist available for research purposes only. Its powerful combination of receptor activity has shown promising results in research for weight loss and metabolic health. Available in 10mg, 20mg, and 30mg, Tirzepatide offers an innovative approach for researchers exploring advanced metabolic and weight loss solutions.

Key Benefits:

• For research purposes only
• Dual-action mechanism (GLP-1 and GIP) for enhanced metabolic effects
• Available in 10mg, 20mg, and 30mg doses for flexible research

Ideal for advanced weight loss and metabolic health studies